Gross Profit On Sales Veränderung Datum
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Cara Therapeutics USD 3.31M 2.21M 2023-09
Cipla INR 43.65B 2.73B 2023-09
Compugen USD 6.52M 6.52M 2022-12
CSL USD 2.98B 882.4M 2023-06
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Grifols EUR 631.83M 13.37M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Heron Therapeutics USD 13.23M 1.62M 2023-09
Insmed USD 65.25M 2.88M 2023-12
Ligand Pharmaceuticals USD 26.46M 2.92M 2023-12
MannKind USD 40.4M 3.41M 2023-12
Merck EUR 3.01B 152M 2023-09
Moderna USD 1.88B 2.29B 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Acorda Therapeutics Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.